Suggestions
Michael Henry
CBO at Aldatu Biosciences | Leader in adaptive PCR diagnostics for global health and emerging diseases
Professional Background
Mike Henry is a distinguished Chief Business Officer with an extensive record of accomplishments in the biotechnology sector, specifically in molecular diagnostics. Currently, he serves at Aldatu Biosciences, a pioneering company focused on adaptive PCR diagnostics that plays an integral role in global health and addresses emerging diseases. With over 20 years of senior leadership experience, Mike has shown remarkable expertise in business development, having contributed significantly to various prestigious biotechnology firms, including Ancestry, Quest Diagnostics, Thermo Fisher, and Athena Diagnostics. His deep understanding of medical technology transfer from academic medical centers complements his profile as a leader adept at fostering collaboration between research institutions and commercial entities.
Throughout his career, Mike has played a pivotal role in strategic business decisions and transformations that have shaped the landscape of medical diagnostics. Notably, in 2011, he successfully orchestrated the sale of Athena Diagnostics to Quest Diagnostics for an impressive $740 million, underscoring his exceptional proficiency in mergers and acquisitions. His leadership has led to innovative product development and strategic partnerships that advance the mission of companies he has been part of.
In addition to his executive roles, Mike has made significant contributions to emerging biotechnology startups as an advisor and participant in the Berkeley Angel Network. His commitment to fostering innovation and entrepreneurship extends to mentoring new ventures, helping to shape the future of health technology through strategic insights and support.
Education and Achievements
Mike Henry has a strong academic foundation that underpins his expertise in biotechnology and business. He holds an MBA from the prestigious Haas School of Business at the University of California, Berkeley, where he honed his skills in business management and strategic decision-making. Additionally, he completed both his MA and BS in Botany at the University of California, Berkeley, and the University of Michigan, respectively. This extensive academic background in science combined with business acumen uniquely positions him to navigate the complexities of the biotechnology landscape successfully.
His notable achievements include holding key positions at several reputable organizations. Mike was previously the Senior Vice President and General Manager of Consumer Genomics at Centrillion Biosciences, Inc., where he drove advancements in consumer-driven genetic testing. He also served as Vice President of Business Development at Ancestry, where he expanded the scope of genetic research and consumer genomics.
Mike has been actively involved in various leadership capacities, including serving on boards of several biotech firms such as AboGen, Inc. and Cognoptix, Inc. He was also a vital force at Avant Immunotherapeutics, where he led business development efforts, significantly impacting the company's growth trajectory. His earlier roles at prestigious institutions like the University of Massachusetts Medical School and Children’s Hospital of Philadelphia illustrate his versatility and expertise in technology transfer and entrepreneurial ventures in life sciences.
Achievements
- Sale of Athena Diagnostics: Successfully directed the sale of Athena Diagnostics to Quest Diagnostics for $740 million in 2011, marking a significant milestone in his career.
- Leadership in Biotechnology Companies: Held senior leadership roles across various prominent firms, shaping business strategies that have led to innovative breakthroughs in diagnostics and consumer genetics.
- Mentoring and Advising Startups: Actively involved in the mentorship of biotech startups through the Berkeley Angel Network, contributing to the ecosystem of innovation in life sciences.
- Diverse International Experience: Given his various roles, Mike has garnered vast exposure to international markets in the biotechnology arena, enhancing the global reach of the companies he has been associated with.
- Extensive Networking: Built a solid network of industry contacts and relationships that provide strategic advantages to the companies he works with, demonstrating his expertise in navigating complex business landscapes.
- Impact on Global Health: Through his work, particularly at Aldatu Biosciences, he continues to contribute to enhancing global health standards and responses to emerging diseases through innovative diagnostic solutions.
